The advancements in genomics and biomedical technologies have generated vast amounts
of biological and physiological data, which present opportunities for understanding human …

The vast amount of available sequencing data allows the scientific community to explore
different genetic alterations that may drive cancer or favor cancer progression. Software …

G protein-coupled receptors (GPCRs) are the largest drug target family. Unfortunately,
applications of GPCRs in cancer therapy are scarce due to very limited knowledge …

Background Patients with bone metastasis often experience a significantly limited survival
time, and a life expectancy of< 3 months is generally regarded as a contraindication for …

Identifying cancer driver genes plays a curial role in the development of precision oncology
and cancer therapeutics. Although a plethora of methods have been developed to tackle this …

Cancer genomics is dedicated to elucidating the genes and pathways that contribute to
cancer progression and development. Identifying cancer genes (CGs) associated with the …

Cancer genomics and cancer mutation databases have made an available wealth of
information about missense mutations found in cancer patient samples. Contextualizing by …

Identifying driver genes contributing to the occurrence and development of cancers plays a
critical role in cancer research and treatment. Some recent computational approaches …

Cancer driver genes are critical in driving tumor cell growth, and precisely identifying these
genes is crucial in advancing our understanding of cancer pathogenesis and developing …

Accurately identifying cancer driver genes (CDGs) is crucial for guiding cancer treatment
and has recently received great attention from researchers. However, the high complexity …